Axel Walch

Title: Axel Walch: Innovator in Biochemical Analysis

Introduction

Axel Walch is a notable inventor based in Baldham, Germany. He has made significant contributions to the field of biochemical analysis, particularly in the determination of human epidermal growth factor receptor 2 (HER2) expression. His innovative methods have implications for medical diagnostics and treatment strategies.

Latest Patents

Axel Walch holds a patent for a method titled "Determining an expression status of human epidermal growth factor receptor 2 (HER2) in a biological sample." This method involves providing a sample from a subject and measuring the amounts of specific proteins in the sample. The proteins measured have molecular weights that are substantially equal to 4740, 8404, 8419, 8435, 8450, 8455, 8465, 8570, 8607, or 8626 atomic mass units. Additionally, the method includes measuring amounts of human cystein-rich intestinal protein 1 (CRIP1) and its variants. The results are then compared to control amounts to determine the expression of HER2.

Career Highlights

Axel Walch is associated with Bruker Daltonik GmbH, a company known for its advancements in analytical instrumentation. His work at the company has allowed him to focus on innovative solutions in the field of mass spectrometry and biochemical analysis.

Collaborations

Throughout his career, Axel has collaborated with esteemed colleagues such as Sören-Oliver Deininger and Eckhard Belau. These collaborations have fostered a productive environment for research and development in their respective fields.

Conclusion

Axel Walch's contributions to the field of biochemical analysis, particularly through his patent on HER2 expression determination, highlight his role as an innovator. His work continues to influence medical diagnostics and research methodologies.